Predictive value of decreased p27Kip1 protein expression for the recurrence-free and long-term survival of prostate cancer patients

This publication has 30 references indexed in Scilit:

• Modulation of cell cycle control by vitamin D3 and its analogue, EB1089, in human breast cancer cells
  Oncogene, 1997
• Reduced Expression of Cyclin–dependent Kinase Inhibitor p27^Kipl Is Associated with Advanced Stage and Invasiveness of Gastric Carcinomas
  Japanese Journal of Cancer Research, 1997
• A recombinant adenovirus expressing p27Kip1 induces cell cycle arrest and loss of cyclin-Cdk activity in human breast cancer cells
  Oncogene, 1997
• Viewpoint: Putting the Cell Cycle in Order
  Science, 1996
• Molecular analysis of the cyclin-dependent kinase inhibitor family: p16(CDKN2/MTS1/INK4A), p18(INK4C) and p27(Kip1) genes in neuroblastomas
  Cancer, 1996
• Cancer statistics, 1996
  CA: A Cancer Journal for Clinicians, 1996
• Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals
  Cell, 1994
• p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest.
  Genes & Development, 1994
• Deferred Treatment in Clinically Localised Prostatic Carcinoma
  British Journal of Urology, 1992
• NATURAL HISTORY OF LOCALISED PROSTATIC CANCER MANAGED BY CONSERVATIVE THERAPY ALONE
  The Lancet, 1988